The Artificial Cornea and Corneal Implant Market size was valued at USD 459.7 Million in 2023 and is expected to reach USD 813.7 Million By 2031 and grow at a CAGR of 7.4% over the forecast period of 2024-2031.
The artificial cornea and corneal implant market refers to the market for medical devices and implants designed to replace or repair damaged corneas. The cornea is the transparent outermost layer of the eye that plays a vital role in focusing light onto the retina. Various conditions, such as corneal diseases, trauma, infections, or genetic disorders, can lead to corneal damage or vision loss, requiring interventions such as corneal transplantation or the use of artificial corneas. Artificial corneas, also known as keratoprostheses, are prosthetic devices designed to replace a damaged or diseased cornea. They are typically made from biocompatible materials, such as synthetic polymers or biological tissues, and are intended to restore vision by providing a clear optical surface. Artificial corneas can be either fully synthetic or a combination of synthetic and biological components. Corneal implants, on the other hand, are devices that are used to augment or support the existing corneal structure. They are often used in cases where a full corneal replacement is not necessary. Corneal implants may be in the form of rings, segments, or inserts that are placed within the cornea to reshape it or address specific visual disorders like keratoconus.
To Get More Information on Artificial Cornea and Corneal Implant Market - Request Sample Report
The artificial cornea and corneal implant market has witnessed significant advancements in recent years. These advancements include improvements in implant design, material selection, and surgical techniques, leading to better outcomes and increased acceptance of these procedures. Key players in the market include medical device companies, ophthalmic clinics, and research institutions.
Factors driving the market growth include the rising prevalence of corneal diseases, an ageing population, increasing awareness about available Product options, and advancements in technology. Additionally, the shortage of donor corneas for traditional corneal transplantation has further fueled the demand for artificial corneas and corneal implants. It is estimated that approximately 200,000 corneal transplant procedures are performed annually. While there are still 12.7 million patients waiting for cornea transplants, which means only 1 in 70 of the total need is satisfied. Hence, the huge gap between demand and supply is expected to drive the industry during the forecast period.
The growth of the market includes the increasing prevalence of corneal diseases, the growing population, increasing awareness about available Product options, and advancements in technology.
The number of persons who are blind or have impaired eyesight is also expected to rise considerably.
According to the Royal National Institute of Blind People (RNIB), it is excepted that arrount 4.2 million people will suffer from sight loss by 2050 in the UK. There are currently 144 million people with trachoma worldwide, of whom 10.2 million suffer from trichiasis and require surgery to prevent corneal blindness, and 4.7 million suffer from trachomatous corneal scarring that renders them completely Made blind.
Restrain
Artificial corneas and corneal implants are medical devices that need to adhere to strict regulatory standards and obtain appropriate approvals before they can be marketed and used.
High Costs of Ophthalmology Equipment & Surgeries May Cause Control of The Artificial Cornea and Corneal Implant Market.
The development of the femtosecond laser and other developments in ophthalmic laser technology have shortened operating time, improved surgical results, and increased patient comfort. The expensive expense of this technology, however, is projected to stymie their growth. A new fundus machine costs from $15,000 to $60,000, while an OCT costs from $70,000 to $120,000. All these factors are hindering the expansion of the market.
Opportunity
The prevalence of corneal diseases, such as corneal scarring, keratoconus, and corneal dystrophies, is increasing globally.
A huge shortage of corneal donors around the world that can be useful in the future.
There is a critical need for corneal donors worldwide, as approximately 10.1 million people require corneal transplants, but densely populated countries such as India also suffer from an acute shortage of donor corneas, and there is a high demand for corneal transplants among patients suffering from corneal blindness. have a waiting period of more than six months and such a long period can prove fatal to their eyes
Challenge
Surgeons need to be well-trained in the specific techniques and procedures associated with these devices.
The shortage of ophthalmologists is the biggest challenge in this market.
The demand for ophthalmologists has increased substantially in proportion to the increase in population, but globally their numbers have not increased. And this is especially seen in developing countries.
Negative impacts of the Russia-Ukraine war were seen especially across Eastern & Central Asia, European Union, the United States, and Eastern Europe. Impact on this sector was not only seen in Russia and Ukraine but the impact of this war can be seen in the whole world, be it from any sector. Healthcare sector is such a sector that every developing country has to make efforts to make it better, but such a sub-war hinders future development. Russia is a very developing country with good healthcare sector.
Things related to healthcare in Russia were available at a reasonable price, but due to this war, Russia has increased the tax on the company outside Russia, as a result of which the company related Artificial Cornea and Corneal Implant products increased the price of its service much more than before, due to which the profits of the companies in the healthcare sector have declined by 2-3%.
Impact of Ongoing Recession
Inflationary pressures in developed nations have resulted in a global price increase during the last two years. The gradually declining gross buying power is necessary to have a substantial influence on evolving economies and is deemed beneficial in a variety of ways. The research investigates the impact of high inflation on the long-term performance of the global economy or offers guidance on fiscal policies for assessing and lowering its short-term impact on currency exchange, cash flow, and demand and supply. report The Artificial Cornea and Corneal Implant Market has high inflation forecasts due to the combined influence of demand-pull and cost-push inflation.
Artificial Cornea and Corneal Implant Market is a high-cost therapy. If the inflation rate is high the normal person is not to purchase the service. It also impacts new research & development in the company.
By Type
Artificial Cornea
Human Cornea
By Transplant Type
Endothelial Keratoplasty
Penetrating Keratoplasty
Keratoprosthesis
Anterior Lamellar Keratoplasty
By Disease Indication
Fungal Keratitis
Fuchs' Dystrophy
Keratoconus
Others
By End User
Hospitals
Specialty Clinics
Do You Need any Customization Research on Artificial Cornea and Corneal Implant Market - Enquire Now
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Regional Analysis
North America & Europe: North America rule the roost industry in 2021 & accounted for the biggest share of around 59.25% of the gross revenue. Domicile of general market players, efficient compensation policies, & increasing R&D activities affined to corneal implants are the component expected to warden the region’s growth forward. For example, CorneaGen has cooperated a nigh the Institute of Regenerative Medicine to generate corneas from the prototype of stem cells. Europe held the second-biggest industry share in 2021. Corneal contain procedures have been highly markedly done over the years, especially in the U.K. European countries, Italy, Germany, and Spain.
Asia-Pacific: The Asia-Pacific region is expected to witness significant growth in the artificial cornea and corneal implant market. Countries such as China, Japan, and South Korea have large populations, a high prevalence of corneal diseases, and increasing healthcare expenditures. The region also benefits from a growing emphasis on improving healthcare infrastructure and access to care, creating opportunities for market expansion.
The major players are Alabama Eye Bank, Inc, Alcon, Inc. DIOPTEX, CorneaGen, AJL Ophthalmic SA, Aurolab, KeraMed, Inc, San Diego Eye Bank, Massachusetts Eye and Ear, Florida Lions Eye Bank, Presbia Plc and others.
AJL Ophthalmic In 2020, AJL Ophthalmic derived CE Mark approval for ENDO-K PRO. Goods. approval will viable the company to provide its reports to end users.
Mediphacos In 2020, Mediphacos launched the Keraring Intrastromal Corneal Ring. This product launch will viable the company to hold market share.
| Report Attributes | Details |
| Market Size in 2022 | US$ 428 Mn |
| Market Size by 2030 | US$ 746.45 Mn |
| CAGR | CAGR of 7.2 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Artificial Cornea and Human Cornea) • By Transplant Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Keratoprosthesis, and Anterior Lamellar Keratoplasty) • By Disease Indication (Fungal Keratitis, Fuchs' Dystrophy, Keratoconus, Others) • By End User (Ambulatory Surgical Centers, Hospitals and Specialty Clinics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa]), Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Alabama Eye Bank, Inc, Alcon, Inc. DIOPTEX, CorneaGen, AJL Ophthalmic SA, Aurolab, KeraMed, Inc, San Diego Eye Bank, Massachusetts Eye and Ear, Florida Lions Eye Bank, Presbia Plc |
| Key Drivers | • The growth of the market includes the increasing prevalence of corneal diseases, the growing population, increasing awareness about available Product options, and advancements in technology. • The number of persons who are blind or have impaired eyesight is also expected to rise considerably. |
| Market Opportunities | • The prevalence of corneal diseases, such as corneal scarring, keratoconus, and corneal dystrophies, is increasing globally. • A huge shortage of corneal donors around the world that can be useful in the future. |
Ans. The Compound Annual Growth rate for Artificial Cornea and Corneal Implants Market over the forecast period is 7.4%.
Ans. The Artificial Cornea and Corneal Implants market size is projected to reach USD 813.7 Million By 2031.
Ans. North America is the fastest-growing region of the Artificial Cornea and Corneal Implants Market.
Ans. The major key players are Alabama Eye Bank, Inc, Alcon, Inc. DIOPTEX, CorneaGen, AJL Ophthalmic SA, Aurolab, KeraMed, Inc, San Diego Eye Bank, Massachusetts Eye and Ear, Florida Lions Eye Bank, Presbia Plc and other key players mentioned in the report.
Ans. The key drivers are the artificial corneal implants market growth including increasing prevalence of corneal disorders, shortage of human corneas and increasing demand for corneal transplants.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine-Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Artificial Cornea and Corneal Implant Market Segmentation, By Type
8.1 Artificial Cornea
8.2 Human Cornea
9. Artificial Cornea and Corneal Implant Market Segmentation, ByTransplant Type
9.1 Endothelial Keratoplasty
9.2 Penetrating Keratoplasty
9.3 Keratoprosthesis
9.4 Anterior Lamellar Keratoplasty
10. Artificial Cornea and Corneal Implant Market Segmentation, By Disease Indication
10.1 Fungal Keratitis
10.2 Fuchs' Dystrophy
10.3 Keratoconus
10.4 Others
11. Artificial Cornea and Corneal Implant Market Segmentation, ByEnd User
11.1 Ambulatory Surgical Centers,
11.2 Hospitals
11.3 Specialty Clinics
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Artificial Cornea and Corneal Implant Market by Country
12.2.2 North America Artificial Cornea and Corneal Implant Market by Type
12.2.3 North America Artificial Cornea and Corneal Implant Market by Transplant Type
12.2.4 North America Artificial Cornea and Corneal Implant Market by Disease Indication
12.2.5 North America Artificial Cornea and Corneal Implant Market by End User
12.2.6 USA
12.2.6.1 USA Artificial Cornea and Corneal Implant Market by Type
12.2.6.2 USA Artificial Cornea and Corneal Implant Market by Transplant Type
12.2.6.3 USA Artificial Cornea and Corneal Implant Market by Disease Indication
12.2.6.4 USA Artificial Cornea and Corneal Implant Market by End User
12.2.7 Canada
12.2.7.1 Canada Artificial Cornea and Corneal Implant Market by Type
12.2.7.2 Canada Artificial Cornea and Corneal Implant Market by Transplant Type
12.2.7.3 Canada Artificial Cornea and Corneal Implant Market by Disease Indication
12.2.7.4 Canada Artificial Cornea and Corneal Implant Market by End User
12.2.8 Mexico
12.2.8.1 Mexico Artificial Cornea and Corneal Implant Market by Raw Technology
12.2.8.2 Mexico Artificial Cornea and Corneal Implant Market by Transplant Type
12.2.8.3 Mexico Artificial Cornea and Corneal Implant Market by Disease Indication
12.2.8.4 Mexico Artificial Cornea and Corneal Implant Market by End User
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Eastern Europe Artificial Cornea and Corneal Implant Market by Country
12.3.1.2 Eastern Europe Artificial Cornea and Corneal Implant Market by Type
12.3.1.3 Eastern Europe Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.1.4 Eastern Europe Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.1.5 Eastern Europe Artificial Cornea and Corneal Implant Market by End User
12.3.1.6 Poland
12.3.1.6.1 Poland Artificial Cornea and Corneal Implant Market by Type
12.3.1.6.2 Poland Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.1.6.3 Poland Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.1.6.4 Poland Artificial Cornea and Corneal Implant Market by End User
12.3.1.7 Romania
12.3.1.7.1 Romania Artificial Cornea and Corneal Implant Market by Type
12.3.1.7.2 Romania Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.1.7.3 Romania Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.1.7.4 Romania Artificial Cornea and Corneal Implant Market by End User
12.3.1.8 Hungary
12.3.1.8.1 Hungary Artificial Cornea and Corneal Implant Market by Type
12.3.1.8.2 Hungary Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.1.8.3 Hungary Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.1.8.4 Hungary Artificial Cornea and Corneal Implant Market by End User
12.3.1.9 Turkey
12.3.1.9.1 Turkey Artificial Cornea and Corneal Implant Market by Type
12.3.1.9.2 Turkey Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.1.9.3 Turkey Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.1.9.4 Turkey Artificial Cornea and Corneal Implant Market by End User
12.3.1.10 Rest of Eastern Europe
12.3.1.10.1 Rest of Eastern Europe Artificial Cornea and Corneal Implant Market by Type
12.3.1.10.2 Rest of Eastern Europe Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.1.10.3 Rest of Eastern Europe Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.1.10.4 Rest of Eastern Europe Artificial Cornea and Corneal Implant Market by End User
12.3.2 Western Europe
12.3.2.1 Western Europe Artificial Cornea and Corneal Implant Market by Country
12.3.2.2 Western Europe Artificial Cornea and Corneal Implant Market by Type
12.3.2.3 Western Europe Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.4 Western Europe Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.5 Western Europe Artificial Cornea and Corneal Implant Market by End User
12.3.2.6 Germany
12.3.2.6.1 Germany Artificial Cornea and Corneal Implant Market by Type
12.3.2.6.2 Germany Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.6.3 Germany Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.6.4 Germany Artificial Cornea and Corneal Implant Market by End User
12.3.2.7 France
12.3.2.7.1 France Artificial Cornea and Corneal Implant Market by Type
12.3.2.7.2 France Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.7.3 France Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.7.4 France Artificial Cornea and Corneal Implant Market by End User
12.3.2.8 UK
12.3.2.8.1 UK Artificial Cornea and Corneal Implant Market by Type
12.3.2.8.2 UK Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.8.3 UK Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.8.4 UK Artificial Cornea and Corneal Implant Market by End User
12.3.2.9 Italy
12.3.2.9.1 Italy Artificial Cornea and Corneal Implant Market by Type
12.3.2.9.2 Italy Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.9.3 Italy Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.9.4 Italy Artificial Cornea and Corneal Implant Market by End User
12.3.2.10 Spain
12.3.2.10.1 Spain Artificial Cornea and Corneal Implant Market by Type
12.3.2.10.2 Spain Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.10.3 Spain Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.10.4 Spain Artificial Cornea and Corneal Implant Market by End User
12.3.2.11 Netherlands
12.3.2.11.1 Netherlands Artificial Cornea and Corneal Implant Market by Type
12.3.2.11.2 Netherlands Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.11.3 Netherlands Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.11.4 Netherlands Artificial Cornea and Corneal Implant Market by End User
12.3.2.12 Switzerland
12.3.2.12.1 Switzerland Artificial Cornea and Corneal Implant Market by Type
12.3.2.12.2 Switzerland Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.12.3 Switzerland Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.12.4 Switzerland Artificial Cornea and Corneal Implant Market by End User
12.3.2.13 Austria
12.3.2.13.1 Austria Artificial Cornea and Corneal Implant Market by Type
12.3.2.13.2 Austria Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.13.3 Austria Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.13.4 Austria Artificial Cornea and Corneal Implant Market by End User
12.3.2.14 Rest of Western Europe
12.3.2.14.1 Rest of Western Europe Artificial Cornea and Corneal Implant Market by Type
12.3.2.14.2 Rest of Western Europe Artificial Cornea and Corneal Implant Market by Transplant Type
12.3.2.14.3 Rest of Western Europe Artificial Cornea and Corneal Implant Market by Disease Indication
12.3.2.14.4 Rest of Western Europe Artificial Cornea and Corneal Implant Market by End User
12.4 Asia-Pacific
12.4.1 Asia Pacific Artificial Cornea and Corneal Implant Market by Country
12.4.2 Asia Pacific Artificial Cornea and Corneal Implant Market by Type
12.4.3 Asia Pacific Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.4 Asia Pacific Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.5 Asia Pacific Artificial Cornea and Corneal Implant Market by End User
12.4.6 China
12.4.6.1 China Artificial Cornea and Corneal Implant Market by Type
12.4.6.2 China Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.6.3 China Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.6.4 China Artificial Cornea and Corneal Implant Market by End User
12.4.7 India
12.4.7.1 India Artificial Cornea and Corneal Implant Market by Type
12.4.7.2 India Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.7.3 India Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.7.4 India Artificial Cornea and Corneal Implant Market by End User
12.4.8 Japan
12.4.8.1 Japan Artificial Cornea and Corneal Implant Market by Type
12.4.8.2 Japan Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.8.3 Japan Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.8.4 Japan Artificial Cornea and Corneal Implant Market by End User
12.4.9 South Korea
12.4.9.1 South Korea Artificial Cornea and Corneal Implant Market by Type
12.4.9.2 South Korea Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.9.3 South Korea Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.9.4 South Korea Artificial Cornea and Corneal Implant Market by End User
12.4.10 Vietnam
12.4.10.1 Vietnam Artificial Cornea and Corneal Implant Market by Type
12.4.10.2 Vietnam Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.10.3 Vietnam Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.10.4 Vietnam Artificial Cornea and Corneal Implant Market by End User
12.4.11 Singapore
12.4.11.1 Singapore Artificial Cornea and Corneal Implant Market by Type
12.4.11.2 Singapore Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.11.3 Singapore Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.11.4 Singapore Artificial Cornea and Corneal Implant Market by End User
12.4.12 Australia
12.4.12.1 Australia Artificial Cornea and Corneal Implant Market by Type
12.4.12.2 Australia Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.12.3 Australia Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.12.4 Australia Artificial Cornea and Corneal Implant Market by End User
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Artificial Cornea and Corneal Implant Market by Type
12.4.13.2 Rest of Asia-Pacific Artificial Cornea and Corneal Implant Market by Transplant Type
12.4.13.3 Rest of Asia-Pacific Artificial Cornea and Corneal Implant Market by Disease Indication
12.4.13.4 Rest of Asia-Pacific Artificial Cornea and Corneal Implant Market by End User
12.5 Middle East & Africa
12.5.1 Middle East
12.5.1.1 Middle East Artificial Cornea and Corneal Implant Market by Country
12.5.1.2 Middle East Artificial Cornea and Corneal Implant Market by Type
12.5.1.3 Middle East Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.1.4 Middle East Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.1.5 Middle East Artificial Cornea and Corneal Implant Market by End User
12.5.1.6 UAE
12.5.1.6.1 UAE Artificial Cornea and Corneal Implant Market by Type
12.5.1.6.2 UAE Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.1.6.3 UAE Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.1.6.4 UAE Artificial Cornea and Corneal Implant Market by End User
12.5.1.7 Egypt
12.5.1.7.1 Egypt Artificial Cornea and Corneal Implant Market by Type
12.5.1.7.2 Egypt Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.1.7.3 Egypt Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.1.7.4 Egypt Artificial Cornea and Corneal Implant Market by End User
12.5.1.8 Saudi Arabia
12.5.1.8.1 Saudi Arabia Artificial Cornea and Corneal Implant Market by Type
12.5.1.8.2 Saudi Arabia Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.1.8.3 Saudi Arabia Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.1.8.4 Saudi Arabia Artificial Cornea and Corneal Implant Market by End User
12.5.1.9 Qatar
12.5.1.9.1 Qatar Artificial Cornea and Corneal Implant Market by Type
12.5.1.9.2 Qatar Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.1.9.3 Qatar Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.1.9.4 Qatar Artificial Cornea and Corneal Implant Market by End User
12.5.1.10 Rest of Middle East
12.5.1.10.1 Rest of Middle East Artificial Cornea and Corneal Implant Market by Type
12.5.1.10.2 Rest of Middle East Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.1.10.3 Rest of Middle East Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.1.10.4 Rest of Middle East Artificial Cornea and Corneal Implant Market by End User
12.5.2. Africa
12.5.2.1 Africa Artificial Cornea and Corneal Implant Market by Country
12.5.2.2 Africa Artificial Cornea and Corneal Implant Market by Type
12.5.2.3 Africa Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.2.4 Africa Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.2.5 Africa Artificial Cornea and Corneal Implant Market by End User
12.5.2.6 Nigeria
12.5.2.6.1 Nigeria Artificial Cornea and Corneal Implant Market by Type
12.5.2.6.2 Nigeria Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.2.6.3 Nigeria Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.2.6.4 Nigeria Artificial Cornea and Corneal Implant Market by End User
12.5.2.7 South Africa
12.5.2.7.1 South Africa Artificial Cornea and Corneal Implant Market by Type
12.5.2.7.2 South Africa Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.2.7.3 South Africa Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.2.7.4 South Africa Artificial Cornea and Corneal Implant Market by End User
12.5.2.8 Rest of Africa
12.5.2.8.1 Rest of Africa Artificial Cornea and Corneal Implant Market by Type
12.5.2.8.2 Rest of Africa Artificial Cornea and Corneal Implant Market by Transplant Type
12.5.2.8.3 Rest of Africa Artificial Cornea and Corneal Implant Market by Disease Indication
12.5.2.8.4 Rest of Africa Artificial Cornea and Corneal Implant Market by End User
12.6. Latin America
12.6.1 Latin America Artificial Cornea and Corneal Implant Market by Country
12.6.2 Latin America Artificial Cornea and Corneal Implant Market by Type
12.6.3 Latin America Artificial Cornea and Corneal Implant Market by Transplant Type
12.6.4 Latin America Artificial Cornea and Corneal Implant Market by Disease Indication
12.6.5 Latin America Artificial Cornea and Corneal Implant Market by End User
12.6.6 Brazil
12.6.6.1 Brazil Artificial Cornea and Corneal Implant Market by Type
12.6.6.2 Brazil Artificial Cornea and Corneal Implant Market by Transplant Type
12.6.6.3 Brazil Artificial Cornea and Corneal Implant Market by Disease Indication
12.6.6.4 Brazil Artificial Cornea and Corneal Implant Market by End User
12.6.7 Argentina
12.6.7.1 Argentina Artificial Cornea and Corneal Implant Market by Type
12.6.7.2 Argentina Artificial Cornea and Corneal Implant Market by Transplant Type
12.6.7.3 Argentina Artificial Cornea and Corneal Implant Market by Disease Indication
12.6.7.4 Argentina Artificial Cornea and Corneal Implant Market by End User
12.6.8 Colombia
12.6.8.1 Colombia Artificial Cornea and Corneal Implant Market by Type
12.6.8.2 Colombia Artificial Cornea and Corneal Implant Market by Transplant Type
12.6.8.3 Colombia Artificial Cornea and Corneal Implant Market by Disease Indication
12.6.8.4 Colombia Artificial Cornea and Corneal Implant Market by End User
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Artificial Cornea and Corneal Implant Market by Type
12.6.9.2 Rest of Latin America Artificial Cornea and Corneal Implant Market by Transplant Type
12.6.9.3 Rest of Latin America Artificial Cornea and Corneal Implant Market by Disease Indication
12.6.9.4 Rest of Latin America Artificial Cornea and Corneal Implant Market by End User
13. Company Profile
13.1 Alabama Eye Bank, Inc
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Product/Services/Offerings
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Alcon, Inc
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Product/Services/Offerings
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 DIOPTEX
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Product/Services/Offerings
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 AJL Ophthalmic SA
13.4 Market Overview
13.4.2 Financials
13.4.3 Product/Services/Offerings
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Aurolab
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Product/Services/Offerings
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 KeraMed, Inc
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Product/Services/Offerings
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 San Diego Eye Bank
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Product/Services/Offerings
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Massachusetts Eye and Ear
13.8.1 Market Overview
13.8.2 Financials
13.8.3 Product/Services/Offerings
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Florida Lions Eye Bank
13.9.1 Market Overview
13.9.2 Financials
13.9.3 Product/Services/Offerings
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Presbia Plc
13.10.1 Market Overview
13.10.2 Financials
13.10.3 Product/Services/Offerings
13.10.4 SWOT Analysis
13.10.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
15. USE Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Compounding Pharmacies Market Size was valued at USD 12.6 Billion in 2023 and will hit USD 19.9 Billion by 2032 with an emerging CAGR of 5.2% Over the Forecast Period of 2024-2032.
Breathalyzers Market was valued at USD 2.7 billion in 2023 and is expected to reach USD 10.9 billion by 2032, growing at a CAGR of 16.74% from 2024 to 2032.
The Oncology Drugs Market size was USD 221.38 Billion in 2023 and is expected to Reach USD 525.08 Billion by 2031 and grow at a CAGR of 11.4% over the forecast period of 2024-2031.
Anesthesia Monitoring Devices Market was valued at USD 2.03 Bn in 2023 and is expected to reach USD 5.26 Bn by 2032, growing at a CAGR of 11.21% from 2024-2032.
The Computerized Physician Order Entry Market Size was valued at USD 1.81 billion in 2023, and expected to reach USD 3.25 billion by 2032, and grow at a CAGR of 6.7% over the forecast period 2024-2032.
The Defibrillator Market size was estimated at USD 7.31 billion in 2023 and is expected to reach USD 14.85 billion by 2032 at a CAGR of 8.2% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
